- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.
According to our latest study, the global Anthrax Vaccines market size was valued at USD 674 million in 2022 and is forecast to a readjusted size of USD 1101.7 million by 2029 with a CAGR of 7.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Anthrax Vaccines key players include Emergent BioSolutions, Merial, Merck, Zoetis, PharmAthene, etc. Global top five players hold a share about 70%.
North America is the largest market, with a share about 60%, followed by Latin America and Europe, having a total share about 20 percent.
In terms of product, Live Vaccines is the largest segment, with a share about 95%. And in terms of application, the largest application is Human Use, followed by Animal Use.
This report is a detailed and comprehensive analysis for global Anthrax Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Anthrax Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Dose), 2018-2029
Global Anthrax Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Dose), 2018-2029
Global Anthrax Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Dose), 2018-2029
Global Anthrax Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (USD/Dose), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anthrax Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anthrax Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Emergent BioSolutions, Merial, Merck, Zoetis and Bayer Sanidad Animal, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Anthrax Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Live Vaccines
Cell free PA Vaccines
Market segment by Application
Human Use
Animal Use
Major players covered
Emergent BioSolutions
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anthrax Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anthrax Vaccines, with price, sales, revenue and global market share of Anthrax Vaccines from 2018 to 2023.
Chapter 3, the Anthrax Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anthrax Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Anthrax Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anthrax Vaccines.
Chapter 14 and 15, to describe Anthrax Vaccines sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Anthrax Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Anthrax Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Live Vaccines
1.3.3 Cell free PA Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Anthrax Vaccines Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Human Use
1.4.3 Animal Use
1.5 Global Anthrax Vaccines Market Size & Forecast
1.5.1 Global Anthrax Vaccines Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Anthrax Vaccines Sales Quantity (2018-2029)
1.5.3 Global Anthrax Vaccines Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Emergent BioSolutions
2.1.1 Emergent BioSolutions Details
2.1.2 Emergent BioSolutions Major Business
2.1.3 Emergent BioSolutions Anthrax Vaccines Product and Services
2.1.4 Emergent BioSolutions Anthrax Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Emergent BioSolutions Recent Developments/Updates
2.2 Merial
2.2.1 Merial Details
2.2.2 Merial Major Business
2.2.3 Merial Anthrax Vaccines Product and Services
2.2.4 Merial Anthrax Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merial Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Anthrax Vaccines Product and Services
2.3.4 Merck Anthrax Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Merck Recent Developments/Updates
2.4 Zoetis
2.4.1 Zoetis Details
2.4.2 Zoetis Major Business
2.4.3 Zoetis Anthrax Vaccines Product and Services
2.4.4 Zoetis Anthrax Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Zoetis Recent Developments/Updates
2.5 Bayer Sanidad Animal
2.5.1 Bayer Sanidad Animal Details
2.5.2 Bayer Sanidad Animal Major Business
2.5.3 Bayer Sanidad Animal Anthrax Vaccines Product and Services
2.5.4 Bayer Sanidad Animal Anthrax Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bayer Sanidad Animal Recent Developments/Updates
2.6 Colorado Serum
2.6.1 Colorado Serum Details
2.6.2 Colorado Serum Major Business
2.6.3 Colorado Serum Anthrax Vaccines Product and Services
2.6.4 Colorado Serum Anthrax Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Colorado Serum Recent Developments/Updates
2.7 PharmAthene
2.7.1 PharmAthene Details
2.7.2 PharmAthene Major Business
2.7.3 PharmAthene Anthrax Vaccines Product and Services
2.7.4 PharmAthene Anthrax Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 PharmAthene Recent Developments/Updates
2.8 Tiankang
2.8.1 Tiankang Details
2.8.2 Tiankang Major Business
2.8.3 Tiankang Anthrax Vaccines Product and Services
2.8.4 Tiankang Anthrax Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Tiankang Recent Developments/Updates
2.9 Biogénesis-Bago
2.9.1 Biogénesis-Bago Details
2.9.2 Biogénesis-Bago Major Business
2.9.3 Biogénesis-Bago Anthrax Vaccines Product and Services
2.9.4 Biogénesis-Bago Anthrax Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Biogénesis-Bago Recent Developments/Updates
2.10 CAVAC
2.10.1 CAVAC Details
2.10.2 CAVAC Major Business
2.10.3 CAVAC Anthrax Vaccines Product and Services
2.10.4 CAVAC Anthrax Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 CAVAC Recent Developments/Updates
2.11 Rosenbusch
2.11.1 Rosenbusch Details
2.11.2 Rosenbusch Major Business
2.11.3 Rosenbusch Anthrax Vaccines Product and Services
2.11.4 Rosenbusch Anthrax Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Rosenbusch Recent Developments/Updates
2.12 Agrovet
2.12.1 Agrovet Details
2.12.2 Agrovet Major Business
2.12.3 Agrovet Anthrax Vaccines Product and Services
2.12.4 Agrovet Anthrax Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Agrovet Recent Developments/Updates
2.13 Vecol
2.13.1 Vecol Details
2.13.2 Vecol Major Business
2.13.3 Vecol Anthrax Vaccines Product and Services
2.13.4 Vecol Anthrax Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Vecol Recent Developments/Updates
2.14 CVCRI
2.14.1 CVCRI Details
2.14.2 CVCRI Major Business
2.14.3 CVCRI Anthrax Vaccines Product and Services
2.14.4 CVCRI Anthrax Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 CVCRI Recent Developments/Updates
2.15 IVPM
2.15.1 IVPM Details
2.15.2 IVPM Major Business
2.15.3 IVPM Anthrax Vaccines Product and Services
2.15.4 IVPM Anthrax Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 IVPM Recent Developments/Updates
2.16 Prondil
2.16.1 Prondil Details
2.16.2 Prondil Major Business
2.16.3 Prondil Anthrax Vaccines Product and Services
2.16.4 Prondil Anthrax Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Prondil Recent Developments/Updates
2.17 CDV
2.17.1 CDV Details
2.17.2 CDV Major Business
2.17.3 CDV Anthrax Vaccines Product and Services
2.17.4 CDV Anthrax Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 CDV Recent Developments/Updates
2.18 Indian Immunologicals
2.18.1 Indian Immunologicals Details
2.18.2 Indian Immunologicals Major Business
2.18.3 Indian Immunologicals Anthrax Vaccines Product and Services
2.18.4 Indian Immunologicals Anthrax Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Indian Immunologicals Recent Developments/Updates
2.19 Botswana Vaccine Institute
2.19.1 Botswana Vaccine Institute Details
2.19.2 Botswana Vaccine Institute Major Business
2.19.3 Botswana Vaccine Institute Anthrax Vaccines Product and Services
2.19.4 Botswana Vaccine Institute Anthrax Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Botswana Vaccine Institute Recent Developments/Updates
2.20 Ceva Santé Animale
2.20.1 Ceva Santé Animale Details
2.20.2 Ceva Santé Animale Major Business
2.20.3 Ceva Santé Animale Anthrax Vaccines Product and Services
2.20.4 Ceva Santé Animale Anthrax Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Ceva Santé Animale Recent Developments/Updates
2.21 Intervac
2.21.1 Intervac Details
2.21.2 Intervac Major Business
2.21.3 Intervac Anthrax Vaccines Product and Services
2.21.4 Intervac Anthrax Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Intervac Recent Developments/Updates
2.22 JOVAC
2.22.1 JOVAC Details
2.22.2 JOVAC Major Business
2.22.3 JOVAC Anthrax Vaccines Product and Services
2.22.4 JOVAC Anthrax Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 JOVAC Recent Developments/Updates
3 Competitive Environment: Anthrax Vaccines by Manufacturer
3.1 Global Anthrax Vaccines Sales Quantity by Manufacturer (2018-2023)
3.2 Global Anthrax Vaccines Revenue by Manufacturer (2018-2023)
3.3 Global Anthrax Vaccines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Anthrax Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Anthrax Vaccines Manufacturer Market Share in 2022
3.4.2 Top 6 Anthrax Vaccines Manufacturer Market Share in 2022
3.5 Anthrax Vaccines Market: Overall Company Footprint Analysis
3.5.1 Anthrax Vaccines Market: Region Footprint
3.5.2 Anthrax Vaccines Market: Company Product Type Footprint
3.5.3 Anthrax Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Anthrax Vaccines Market Size by Region
4.1.1 Global Anthrax Vaccines Sales Quantity by Region (2018-2029)
4.1.2 Global Anthrax Vaccines Consumption Value by Region (2018-2029)
4.1.3 Global Anthrax Vaccines Average Price by Region (2018-2029)
4.2 North America Anthrax Vaccines Consumption Value (2018-2029)
4.3 Europe Anthrax Vaccines Consumption Value (2018-2029)
4.4 Asia-Pacific Anthrax Vaccines Consumption Value (2018-2029)
4.5 South America Anthrax Vaccines Consumption Value (2018-2029)
4.6 Middle East and Africa Anthrax Vaccines Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Anthrax Vaccines Sales Quantity by Type (2018-2029)
5.2 Global Anthrax Vaccines Consumption Value by Type (2018-2029)
5.3 Global Anthrax Vaccines Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Anthrax Vaccines Sales Quantity by Application (2018-2029)
6.2 Global Anthrax Vaccines Consumption Value by Application (2018-2029)
6.3 Global Anthrax Vaccines Average Price by Application (2018-2029)
7 North America
7.1 North America Anthrax Vaccines Sales Quantity by Type (2018-2029)
7.2 North America Anthrax Vaccines Sales Quantity by Application (2018-2029)
7.3 North America Anthrax Vaccines Market Size by Country
7.3.1 North America Anthrax Vaccines Sales Quantity by Country (2018-2029)
7.3.2 North America Anthrax Vaccines Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Anthrax Vaccines Sales Quantity by Type (2018-2029)
8.2 Europe Anthrax Vaccines Sales Quantity by Application (2018-2029)
8.3 Europe Anthrax Vaccines Market Size by Country
8.3.1 Europe Anthrax Vaccines Sales Quantity by Country (2018-2029)
8.3.2 Europe Anthrax Vaccines Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Anthrax Vaccines Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Anthrax Vaccines Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Anthrax Vaccines Market Size by Region
9.3.1 Asia-Pacific Anthrax Vaccines Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Anthrax Vaccines Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Anthrax Vaccines Sales Quantity by Type (2018-2029)
10.2 South America Anthrax Vaccines Sales Quantity by Application (2018-2029)
10.3 South America Anthrax Vaccines Market Size by Country
10.3.1 South America Anthrax Vaccines Sales Quantity by Country (2018-2029)
10.3.2 South America Anthrax Vaccines Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Anthrax Vaccines Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Anthrax Vaccines Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Anthrax Vaccines Market Size by Country
11.3.1 Middle East & Africa Anthrax Vaccines Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Anthrax Vaccines Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Anthrax Vaccines Market Drivers
12.2 Anthrax Vaccines Market Restraints
12.3 Anthrax Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Anthrax Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Anthrax Vaccines
13.3 Anthrax Vaccines Production Process
13.4 Anthrax Vaccines Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Anthrax Vaccines Typical Distributors
14.3 Anthrax Vaccines Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Anthrax Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Anthrax Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Emergent BioSolutions Basic Information, Manufacturing Base and Competitors
Table 4. Emergent BioSolutions Major Business
Table 5. Emergent BioSolutions Anthrax Vaccines Product and Services
Table 6. Emergent BioSolutions Anthrax Vaccines Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Emergent BioSolutions Recent Developments/Updates
Table 8. Merial Basic Information, Manufacturing Base and Competitors
Table 9. Merial Major Business
Table 10. Merial Anthrax Vaccines Product and Services
Table 11. Merial Anthrax Vaccines Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Merial Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck Anthrax Vaccines Product and Services
Table 16. Merck Anthrax Vaccines Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Merck Recent Developments/Updates
Table 18. Zoetis Basic Information, Manufacturing Base and Competitors
Table 19. Zoetis Major Business
Table 20. Zoetis Anthrax Vaccines Product and Services
Table 21. Zoetis Anthrax Vaccines Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Zoetis Recent Developments/Updates
Table 23. Bayer Sanidad Animal Basic Information, Manufacturing Base and Competitors
Table 24. Bayer Sanidad Animal Major Business
Table 25. Bayer Sanidad Animal Anthrax Vaccines Product and Services
Table 26. Bayer Sanidad Animal Anthrax Vaccines Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Bayer Sanidad Animal Recent Developments/Updates
Table 28. Colorado Serum Basic Information, Manufacturing Base and Competitors
Table 29. Colorado Serum Major Business
Table 30. Colorado Serum Anthrax Vaccines Product and Services
Table 31. Colorado Serum Anthrax Vaccines Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Colorado Serum Recent Developments/Updates
Table 33. PharmAthene Basic Information, Manufacturing Base and Competitors
Table 34. PharmAthene Major Business
Table 35. PharmAthene Anthrax Vaccines Product and Services
Table 36. PharmAthene Anthrax Vaccines Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. PharmAthene Recent Developments/Updates
Table 38. Tiankang Basic Information, Manufacturing Base and Competitors
Table 39. Tiankang Major Business
Table 40. Tiankang Anthrax Vaccines Product and Services
Table 41. Tiankang Anthrax Vaccines Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Tiankang Recent Developments/Updates
Table 43. Biogénesis-Bago Basic Information, Manufacturing Base and Competitors
Table 44. Biogénesis-Bago Major Business
Table 45. Biogénesis-Bago Anthrax Vaccines Product and Services
Table 46. Biogénesis-Bago Anthrax Vaccines Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Biogénesis-Bago Recent Developments/Updates
Table 48. CAVAC Basic Information, Manufacturing Base and Competitors
Table 49. CAVAC Major Business
Table 50. CAVAC Anthrax Vaccines Product and Services
Table 51. CAVAC Anthrax Vaccines Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. CAVAC Recent Developments/Updates
Table 53. Rosenbusch Basic Information, Manufacturing Base and Competitors
Table 54. Rosenbusch Major Business
Table 55. Rosenbusch Anthrax Vaccines Product and Services
Table 56. Rosenbusch Anthrax Vaccines Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Rosenbusch Recent Developments/Updates
Table 58. Agrovet Basic Information, Manufacturing Base and Competitors
Table 59. Agrovet Major Business
Table 60. Agrovet Anthrax Vaccines Product and Services
Table 61. Agrovet Anthrax Vaccines Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Agrovet Recent Developments/Updates
Table 63. Vecol Basic Information, Manufacturing Base and Competitors
Table 64. Vecol Major Business
Table 65. Vecol Anthrax Vaccines Product and Services
Table 66. Vecol Anthrax Vaccines Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Vecol Recent Developments/Updates
Table 68. CVCRI Basic Information, Manufacturing Base and Competitors
Table 69. CVCRI Major Business
Table 70. CVCRI Anthrax Vaccines Product and Services
Table 71. CVCRI Anthrax Vaccines Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. CVCRI Recent Developments/Updates
Table 73. IVPM Basic Information, Manufacturing Base and Competitors
Table 74. IVPM Major Business
Table 75. IVPM Anthrax Vaccines Product and Services
Table 76. IVPM Anthrax Vaccines Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. IVPM Recent Developments/Updates
Table 78. Prondil Basic Information, Manufacturing Base and Competitors
Table 79. Prondil Major Business
Table 80. Prondil Anthrax Vaccines Product and Services
Table 81. Prondil Anthrax Vaccines Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Prondil Recent Developments/Updates
Table 83. CDV Basic Information, Manufacturing Base and Competitors
Table 84. CDV Major Business
Table 85. CDV Anthrax Vaccines Product and Services
Table 86. CDV Anthrax Vaccines Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. CDV Recent Developments/Updates
Table 88. Indian Immunologicals Basic Information, Manufacturing Base and Competitors
Table 89. Indian Immunologicals Major Business
Table 90. Indian Immunologicals Anthrax Vaccines Product and Services
Table 91. Indian Immunologicals Anthrax Vaccines Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Indian Immunologicals Recent Developments/Updates
Table 93. Botswana Vaccine Institute Basic Information, Manufacturing Base and Competitors
Table 94. Botswana Vaccine Institute Major Business
Table 95. Botswana Vaccine Institute Anthrax Vaccines Product and Services
Table 96. Botswana Vaccine Institute Anthrax Vaccines Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Botswana Vaccine Institute Recent Developments/Updates
Table 98. Ceva Santé Animale Basic Information, Manufacturing Base and Competitors
Table 99. Ceva Santé Animale Major Business
Table 100. Ceva Santé Animale Anthrax Vaccines Product and Services
Table 101. Ceva Santé Animale Anthrax Vaccines Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. Ceva Santé Animale Recent Developments/Updates
Table 103. Intervac Basic Information, Manufacturing Base and Competitors
Table 104. Intervac Major Business
Table 105. Intervac Anthrax Vaccines Product and Services
Table 106. Intervac Anthrax Vaccines Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Intervac Recent Developments/Updates
Table 108. JOVAC Basic Information, Manufacturing Base and Competitors
Table 109. JOVAC Major Business
Table 110. JOVAC Anthrax Vaccines Product and Services
Table 111. JOVAC Anthrax Vaccines Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 112. JOVAC Recent Developments/Updates
Table 113. Global Anthrax Vaccines Sales Quantity by Manufacturer (2018-2023) & (M Doses)
Table 114. Global Anthrax Vaccines Revenue by Manufacturer (2018-2023) & (USD Million)
Table 115. Global Anthrax Vaccines Average Price by Manufacturer (2018-2023) & (USD/Dose)
Table 116. Market Position of Manufacturers in Anthrax Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 117. Head Office and Anthrax Vaccines Production Site of Key Manufacturer
Table 118. Anthrax Vaccines Market: Company Product Type Footprint
Table 119. Anthrax Vaccines Market: Company Product Application Footprint
Table 120. Anthrax Vaccines New Market Entrants and Barriers to Market Entry
Table 121. Anthrax Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 122. Global Anthrax Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
Table 123. Global Anthrax Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
Table 124. Global Anthrax Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 125. Global Anthrax Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 126. Global Anthrax Vaccines Average Price by Region (2018-2023) & (USD/Dose)
Table 127. Global Anthrax Vaccines Average Price by Region (2024-2029) & (USD/Dose)
Table 128. Global Anthrax Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 129. Global Anthrax Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 130. Global Anthrax Vaccines Consumption Value by Type (2018-2023) & (USD Million)
Table 131. Global Anthrax Vaccines Consumption Value by Type (2024-2029) & (USD Million)
Table 132. Global Anthrax Vaccines Average Price by Type (2018-2023) & (USD/Dose)
Table 133. Global Anthrax Vaccines Average Price by Type (2024-2029) & (USD/Dose)
Table 134. Global Anthrax Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 135. Global Anthrax Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 136. Global Anthrax Vaccines Consumption Value by Application (2018-2023) & (USD Million)
Table 137. Global Anthrax Vaccines Consumption Value by Application (2024-2029) & (USD Million)
Table 138. Global Anthrax Vaccines Average Price by Application (2018-2023) & (USD/Dose)
Table 139. Global Anthrax Vaccines Average Price by Application (2024-2029) & (USD/Dose)
Table 140. North America Anthrax Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 141. North America Anthrax Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 142. North America Anthrax Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 143. North America Anthrax Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 144. North America Anthrax Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
Table 145. North America Anthrax Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
Table 146. North America Anthrax Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 147. North America Anthrax Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 148. Europe Anthrax Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 149. Europe Anthrax Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 150. Europe Anthrax Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 151. Europe Anthrax Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 152. Europe Anthrax Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
Table 153. Europe Anthrax Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
Table 154. Europe Anthrax Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 155. Europe Anthrax Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 156. Asia-Pacific Anthrax Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 157. Asia-Pacific Anthrax Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 158. Asia-Pacific Anthrax Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 159. Asia-Pacific Anthrax Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 160. Asia-Pacific Anthrax Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
Table 161. Asia-Pacific Anthrax Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
Table 162. Asia-Pacific Anthrax Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 163. Asia-Pacific Anthrax Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 164. South America Anthrax Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 165. South America Anthrax Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 166. South America Anthrax Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 167. South America Anthrax Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 168. South America Anthrax Vaccines Sales Quantity by Country (2018-2023) & (M Doses)
Table 169. South America Anthrax Vaccines Sales Quantity by Country (2024-2029) & (M Doses)
Table 170. South America Anthrax Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 171. South America Anthrax Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 172. Middle East & Africa Anthrax Vaccines Sales Quantity by Type (2018-2023) & (M Doses)
Table 173. Middle East & Africa Anthrax Vaccines Sales Quantity by Type (2024-2029) & (M Doses)
Table 174. Middle East & Africa Anthrax Vaccines Sales Quantity by Application (2018-2023) & (M Doses)
Table 175. Middle East & Africa Anthrax Vaccines Sales Quantity by Application (2024-2029) & (M Doses)
Table 176. Middle East & Africa Anthrax Vaccines Sales Quantity by Region (2018-2023) & (M Doses)
Table 177. Middle East & Africa Anthrax Vaccines Sales Quantity by Region (2024-2029) & (M Doses)
Table 178. Middle East & Africa Anthrax Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 179. Middle East & Africa Anthrax Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 180. Anthrax Vaccines Raw Material
Table 181. Key Manufacturers of Anthrax Vaccines Raw Materials
Table 182. Anthrax Vaccines Typical Distributors
Table 183. Anthrax Vaccines Typical Customers
List of Figures
Figure 1. Anthrax Vaccines Picture
Figure 2. Global Anthrax Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Anthrax Vaccines Consumption Value Market Share by Type in 2022
Figure 4. Live Vaccines Examples
Figure 5. Cell free PA Vaccines Examples
Figure 6. Global Anthrax Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Anthrax Vaccines Consumption Value Market Share by Application in 2022
Figure 8. Human Use Examples
Figure 9. Animal Use Examples
Figure 10. Global Anthrax Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Anthrax Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Anthrax Vaccines Sales Quantity (2018-2029) & (M Doses)
Figure 13. Global Anthrax Vaccines Average Price (2018-2029) & (USD/Dose)
Figure 14. Global Anthrax Vaccines Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Anthrax Vaccines Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Anthrax Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Anthrax Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Anthrax Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Anthrax Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Anthrax Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Anthrax Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Anthrax Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Anthrax Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Anthrax Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Anthrax Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Anthrax Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Anthrax Vaccines Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Anthrax Vaccines Average Price by Type (2018-2029) & (USD/Dose)
Figure 29. Global Anthrax Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Anthrax Vaccines Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Anthrax Vaccines Average Price by Application (2018-2029) & (USD/Dose)
Figure 32. North America Anthrax Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Anthrax Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Anthrax Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Anthrax Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Anthrax Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Anthrax Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Anthrax Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Anthrax Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Anthrax Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Anthrax Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Anthrax Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Anthrax Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Anthrax Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Anthrax Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Anthrax Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Anthrax Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Anthrax Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Anthrax Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Anthrax Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Anthrax Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 52. China Anthrax Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Anthrax Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Anthrax Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Anthrax Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Anthrax Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Anthrax Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Anthrax Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Anthrax Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Anthrax Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Anthrax Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Anthrax Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Anthrax Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Anthrax Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Anthrax Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Anthrax Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Anthrax Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Anthrax Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Anthrax Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Anthrax Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Anthrax Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Anthrax Vaccines Market Drivers
Figure 73. Anthrax Vaccines Market Restraints
Figure 74. Anthrax Vaccines Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Anthrax Vaccines in 2022
Figure 77. Manufacturing Process Analysis of Anthrax Vaccines
Figure 78. Anthrax Vaccines Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
